162 related articles for article (PubMed ID: 32243966)
1. Preparation and characterization of glimepiride eutectic mixture with l-arginine for improvement of dissolution rate.
Park H; Seo HJ; Ha ES; Hong SH; Kim JS; Kim MS; Hwang SJ
Int J Pharm; 2020 May; 581():119288. PubMed ID: 32243966
[TBL] [Abstract][Full Text] [Related]
2. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods.
Park H; Jin Seo H; Hong SH; Ha ES; Lee S; Kim JS; Baek IH; Kim MS; Hwang SJ
Int J Pharm; 2020 May; 581():119232. PubMed ID: 32240805
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Piperine as Natural Coformer for Eutectics Preparation of Drugs Used in the Treatment of Cardiovascular Diseases.
Wilhelm-Romero K; Quirós-Fallas MI; Vega-Baudrit JR; Guillén-Girón T; Vargas-Huertas F; Navarro-Hoyos M; Araya-Sibaja AM
AAPS PharmSciTech; 2022 Apr; 23(5):127. PubMed ID: 35474407
[TBL] [Abstract][Full Text] [Related]
4. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
5. Saquinavir-Piperine Eutectic Mixture: Preparation, Characterization, and Dissolution Profile.
Fandaruff C; Quirós-Fallas MI; Vega-Baudrit JR; Navarro-Hoyos M; Lamas DG; Araya-Sibaja AM
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896206
[TBL] [Abstract][Full Text] [Related]
6. Determination of the interaction between glimepiride and hyperbranched polymers in solid dispersions.
Pahovnik D; Reven S; Grdadolnik J; Borštnar R; Mavri J; Zagar E
J Pharm Sci; 2011 Nov; 100(11):4700-9. PubMed ID: 21656768
[TBL] [Abstract][Full Text] [Related]
7. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
Dugar RP; Gajera BY; Dave RH
AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
[TBL] [Abstract][Full Text] [Related]
8. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin.
Taupitz T; Dressman JB; Klein S
Eur J Pharm Biopharm; 2013 May; 84(1):208-18. PubMed ID: 23246797
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of dissolution rate through eutectic mixture and solid solution of posaconazole and benznidazole.
Figueirêdo CBM; Nadvorny D; de Medeiros Vieira ACQ; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; de La Roca Soares MF
Int J Pharm; 2017 Jun; 525(1):32-42. PubMed ID: 28412452
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide.
Aggarwal AK; Jain S
Chem Pharm Bull (Tokyo); 2011; 59(5):629-38. PubMed ID: 21532202
[TBL] [Abstract][Full Text] [Related]
13. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
Huang BB; Liu DX; Liu K; Wu G
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
[TBL] [Abstract][Full Text] [Related]
14. Dissolution, solubility, XRD, and DSC studies on flurbiprofen-nicotinamide solid dispersions.
Varma MM; Pandi JK
Drug Dev Ind Pharm; 2005 May; 31(4-5):417-23. PubMed ID: 16093207
[TBL] [Abstract][Full Text] [Related]
15. Hyperbranched poly(esteramides) as solubility enhancers for poorly water-soluble drug glimepiride.
Reven S; Grdadolnik J; Kristl J; Zagar E
Int J Pharm; 2010 Aug; 396(1-2):119-26. PubMed ID: 20600725
[TBL] [Abstract][Full Text] [Related]
16. How tenofovir disoproxil fumarate can impact on solubility and dissolution rate of efavirenz?
Bazzo GC; Mostafa D; França MT; Pezzini BR; Stulzer HK
Int J Pharm; 2019 Oct; 570():118597. PubMed ID: 31401297
[TBL] [Abstract][Full Text] [Related]
17. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000.
Vijaya Kumar SG; Mishra DN
Yakugaku Zasshi; 2006 Aug; 126(8):657-64. PubMed ID: 16880724
[TBL] [Abstract][Full Text] [Related]
19. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
